{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:40:35Z","timestamp":1791463235687,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.heliyon.2023.e15774","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T20:43:43Z","timestamp":1682455423000},"page":"e15774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy and safety of intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of multidrug-resistant gram-negative bacterial pneumonia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"9","author":[{"given":"Difan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5796-5987","authenticated-orcid":false,"given":"Wenchao","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e15774_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/1471-2334-13-561","article-title":"A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study","volume":"13","author":"Quartin","year":"2013","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15774_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/idr13020038","article-title":"Antimicrobial susceptibility among pathogens isolated in early- versus late-onset ventilator-associated pneumonia","volume":"13","author":"Ben Lakhal","year":"2021","journal-title":"Infect. Dis. Rep."},{"issue":"suppl_2","key":"10.1016\/j.heliyon.2023.e15774_bib3","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1093\/cid\/ciy692","article-title":"The current epidemiological landscape of ventilator-associated pneumonia in the intensive care unit: a multicenter prospective observational study in China","volume":"67","author":"Xie","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15774_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3855\/jidc.12012","article-title":"Microbiological profile of ventilator-associated pneumonia among intensive care unit patients in tertiary Egyptian hospitals","volume":"14","author":"Farag","year":"2020","journal-title":"J. Infect. Dev. Ctries."},{"issue":"41","key":"10.1016\/j.heliyon.2023.e15774_bib5","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e251","article-title":"The distribution of multidrug-resistant microorganisms and treatment status of hospital-acquired pneumonia\/ventilator-associated pneumonia in adult intensive care units: a prospective cohort observational study","volume":"36","author":"Chang","year":"2021","journal-title":"J. Kor. Med. Sci."},{"issue":"20\u201321","key":"10.1016\/j.heliyon.2023.e15774_bib6","first-page":"345","article-title":"Treatment options for carbapenem-resistant gram-negative infections","volume":"115","author":"Fritzenwanker","year":"2018","journal-title":"Dtsch Arztebl Int."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15774_bib7","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/22221751.2020.1754133","article-title":"Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019)","volume":"9","author":"El-Sayed Ahmed","year":"2020","journal-title":"Emerg. Microb. Infect."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15774_bib8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/pharmrev.120.000020","article-title":"Rescuing the last-line polymyxins: achievements and challenges","volume":"73","author":"Nang","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.heliyon.2023.e15774_bib9","first-page":"S1198","article-title":"Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins","author":"Wagenlehner","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e15774_bib10","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1177\/1060028017723934","article-title":"An update on aerosolised antibiotics for treating hospital-acquired and ventilator-associated pneumonia in adults","volume":"51","author":"Wood","year":"2017","journal-title":"Ann. Pharmacother."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e15774_bib11","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.cmi.2019.04.018","article-title":"Why don't we have more inhaled antibiotics to treat ventilator-associated pneumonia?","volume":"25","author":"Sweeney","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15774_bib12","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e15774_bib13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cmi.2017.04.011","article-title":"Use of nebulised antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases","volume":"23","author":"Rello","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15774_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jinf.2018.02.002","article-title":"Intravenous plus inhaled versus intravenous colistin monotherapy for lower respiratory tract infections: a systematic review and meta-analysis","volume":"76","author":"Vardakas","year":"2018","journal-title":"J. Infect."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15774_bib15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ijantimicag.2015.09.011","article-title":"Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis","volume":"46","author":"Liu","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"16","key":"10.1016\/j.heliyon.2023.e15774_bib16","first-page":"5275","article-title":"Comparison of different colistin regimens for the treatment of pneumonia caused by multidrug-resistant microorganisms: a systematic review and meta-analysis","volume":"25","author":"Cui","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e15774_bib17","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.cmi.2021.01.020","article-title":"T-CARE (Taiwan Critical Care and Infection) Group. Efficacy of adjunctive nebulised colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study","volume":"27","author":"Feng","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e15774_bib18","first-page":"1194","article-title":"Chinese research hospital association of evidence base and translational infectious diseases. [Chinese expert consensus on polymyxins in the clinical practice]","volume":"31","year":"2019","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15774_bib19","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"Torres","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15774_bib20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejcdt.2013.05.012","article-title":"Re-emerging of colistin for treatment of nosocomial pneumonia due to gram negative multi-drug resistant pathogens in critically ill patients","volume":"62","author":"Amin","year":"2013","journal-title":"Egypt. J. Chest Dis. Tuberc."},{"key":"10.1016\/j.heliyon.2023.e15774_bib21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijid.2021.06.007","article-title":"Aerosolized plus intravenous colistin vs intravenous colistin alone for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: a retrospective Cohort study","volume":"108","author":"Almangour","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2023.e15774_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/1753466619885529","article-title":"Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria","volume":"13","author":"Choe","year":"2019","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15774_bib23","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jmii.2019.08.007","article-title":"Colistin for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex","volume":"53","author":"Zheng","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e15774_bib24","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1080\/14740338.2020.1819980","article-title":"Intravenous vs intravenous plus aerosolised colistin for treatment of ventilator-associated pneumonia - a matched case-control study in neonates","volume":"19","author":"Hussain","year":"2020","journal-title":"Expet Opin. Drug Saf."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15774_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s40272-015-0133-5","article-title":"Treatment of ventilator-associated pneumonia using intravenous colistin alone or in combination with inhaled colistin in critically ill children","volume":"17","author":"Polat","year":"2015","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.heliyon.2023.e15774_bib26","first-page":"29","article-title":"Inhalation plus intravenous colistin versus intravenous colistin alone for treatment of ventilator associated pneumonia","volume":"9","author":"Bogovi\u0107","year":"2014","journal-title":"Signa Vitae"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15774_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2253-13-45","article-title":"Adjunctive aerosolised colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study","volume":"13","author":"Doshi","year":"2013","journal-title":"BMC Anesthesiol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15774_bib28","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s10156-012-0430-7","article-title":"Use of high-dose IV and aerosolised colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?","volume":"18","author":"Kalin","year":"2012","journal-title":"J. Infect. Chemother."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e15774_bib29","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/657242","article-title":"Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study","volume":"51","author":"Kofteridis","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e15774_bib30","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1469-0691.2009.03040.x","article-title":"Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative Cohort study","volume":"16","author":"Korbila","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15774_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000001539","article-title":"The role of aerolized colistin in the treatment of hospital-acquired pneumonia: experience of multicenter from Turkey","volume":"44","author":"Korkmaz Ekren","year":"2016","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.heliyon.2023.e15774_bib32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2334-11-317","article-title":"A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa","volume":"11","author":"Naesens","year":"2011","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15774_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.medin.2011.01.013","article-title":"Utilizaci\u00f3n de la colistina nebulizada en la colonizaci\u00f3n e infecci\u00f3n respiratoria por Acinetobacter baumannii en pacientes cr\u00edticos [Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients]","volume":"35","author":"P\u00e9rez-Pedrero","year":"2011","journal-title":"Med. Intensiva"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15774_bib34","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1378\/chest.13-1018","article-title":"Effect of aerosolised colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria","volume":"144","author":"Tumbarello","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15774_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-016-0123-7","article-title":"Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?","volume":"15","author":"Demirdal","year":"2016","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.heliyon.2023.e15774_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13756-020-00872-w","article-title":"Economic burden of antibiotic resistance in China: a national level estimate for inpatients","volume":"10","author":"Zhen","year":"2021","journal-title":"Antimicrob. Resist. Infect. Control"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15774_bib37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijantimicag.2014.01.007","article-title":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012","volume":"43","author":"Sader","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e15774_bib38","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/jac\/dkx167","article-title":"Pharmacokinetics of nebulised colistin methanesulfonate in critically ill patients","volume":"72","author":"Boisson","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15774_bib39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1513\/AnnalsATS.201311-395FR","article-title":"Inhaled antibiotics for lower airway infections","volume":"11","author":"Quon","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15774_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13613-016-0127-7","article-title":"Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial","volume":"6","author":"Abdellatif","year":"2016","journal-title":"Ann. Intensive Care"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15774_bib41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.heliyon.2023.e15774_bib42","first-page":"S1198","article-title":"Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins","author":"Wagenlehner","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e15774_bib43","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1128\/AAC.03510-14","article-title":"Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients","volume":"58","author":"Boisson","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15774_bib44","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4187\/respcare.04208","article-title":"Aerosolised antibiotics","volume":"60","author":"Restrepo","year":"2015","journal-title":"Respir. Care"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15774_bib45","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4187\/respcare.03790","article-title":"Aerosol therapy in pulmonary critical care","volume":"60","author":"Ari","year":"2015","journal-title":"Respir. Care"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402302981X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402302981X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:14:16Z","timestamp":1773396856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402302981X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S240584402302981X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15774","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of multidrug-resistant gram-negative bacterial pneumonia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e15774"}}